Fusion Antibodies Market Cap

Fusion Antibodies has a market cap or net worth of 7.72 million as of February 21, 2025. Its market cap has increased by 205.69% in one year.

Market Cap

7.72M

Enterprise Value

7.32M

Revenue

1.80M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.05

Market Cap Chart

Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.72M, a decrease of -71.69%. That is a compound annual growth rate of -16.11%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	7.72M	14.18%
Dec 31, 2024	6.76M	167.72%
Dec 29, 2023	2.53M	-78.42%
Dec 30, 2022	11.71M	-59.09%
Dec 31, 2021	28.62M	-9.27%
Dec 31, 2020	31.54M	81.89%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
GSK plc	58.67B
Haleon	35.36B
Smith & Nephew	8.91B
Hikma Pharmaceuticals	5.06B
ConvaTec Group	5.01B
HUTCHMED (China)	1.98B
Oxford Nanopore Technologies	1.24B

Market Cap Rankings